More Company News

Nexstim

Potential new therapeutic use for SmartFocus nTMS in Postsurgical Rehabilitation of Paresis
17 May 2021Read More

Nexstim

New NBS System order from a leading California-based academic hospital
07 May 2021Read More

Nexstim

NBT System order from a new therapy customer in Finland
29 Apr 2021Read More

Nexstim

Q121 business and clinical update
22 Apr 2021Read More

Nexstim

Final results of successful rights issue
07 Apr 2021Read More

Nexstim

Update on promising MDD treatment results
12 Mar 2021Read More

Nexstim

Subscription rights issue of €6.6m
08 Mar 2021Read More

Nexstim

Two new NBS orders in Norway & US
04 Mar 2021Read More

Nexstim

Encouraging results from initial pilot study in severe depression
03 Mar 2021Read More

Nexstim

FY20 financial statements
26 Feb 2021Read More

1 2 3 4 5 6 … 13
Return to Nexstim
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).